HIV and COVID-19: The Data and The Real World

COVID-19 Special Edition

HIV and COVID-19: The Data and The Real World

Editor's note:

In addition to presenting his analysis of the data-driven evidence describing the effects of the COVID-19 virus on people with living with HIV, Dr. Spinelli also spoke directly with front-line clinicians to learn about what they’ve been experiencing as they work to maintain their patients’ health in this disrupted health care system. Transcripts of these interviews can be accessed following the commentary.

In this issue:

What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV?

That’s the dual focus of this eHIV Review Special Edition issue. Matthew Spinelli, MD, MAS, assistant professor in the Division of HIV, ID, and Global Medicine at the University of California, San Francisco and San Francisco General Hospital, analyzes the current literature that addresses these questions, and then speaks directly with front-line clinicians about what they’re experiencing as they navigate a disrupted health care system.

Learning objectives:

Discuss the impact of COVID on the care of patients with or at risk of HIV.
Describe the data pertaining to outcomes for people living with HIV who are hospitalized with COVID-19.

Authors:

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)

Annukka Antar, MD, PhD

Assistant Professor of Medicine
Department of Medicine, Infectious Disease
Johns Hopkins Medicine
Baltimore, Maryland

Jessica Bloome, MD, MPH

Assistant Clinical Professor
HIV, Infectious Disease, and Global Medicine
University of California San Francisco Department of Medicine
San Francisco, California

Elizabeth Lynch, MSN, RN

University of California San Francisco’s Positive Health Program
San Francisco, California

Michael Peluso, MD, MPhil, MHS, DTM&H

Division of HIV, Infectious Diseases, and Global Medicine
University of California San Francisco
San Francisco, California

Chloe Lynne Thio, MD

Professor of Medicine, Department of Medicine
Infectious Disease Infectious Disease Center for Viral Hepatitis
Johns Hopkins Medicine
Baltimore, Maryland

Guest Faculty Disclosures

The authors have indicated that they have no financial interests or relationships with a commercial entity.

Unlabeled/Unapproved Uses

The authors have indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Program Directors:

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)

Justin Alves, RN, FNP-BC, ACRN, CARN, CNE

Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)

Guest Faculty Disclosures:

The authors have indicated that they have no financial interests or relationships with a commercial entity.

Unlabeled/Unapproved Uses:

The authors have indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: December 4, 2020
Expiration date: December 3, 2022

Start Issue